Adicet Bio
ACET
#10726
Rank
A$30.21 M
Marketcap
A$3.23
Share price
-13.01%
Change (1 day)
261.10%
Change (1 year)

Adicet Bio (ACET) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : A$42.26 Million

According to Adicet Bio's latest financial reports the company's total liabilities are A$42.26 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Adicet Bio - Total liabilities on balance sheet (from 2019 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31A$49.48 M-8.42%
2024-12-31A$54.03 M-0.82%
2023-12-31A$54.48 M-3.33%
2022-12-31A$56.35 M14.1%
2021-12-31A$49.39 M-13.7%
2020-12-31A$57.23 M-71.77%
2019-12-31A$0.20 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
A$120.01 B 283,848.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$174.38 B 412,483.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$132.42 B 313,222.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$48.40 B 114,428.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Hawkins
HWKN
A$0.67 B 1,499.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Quaker Houghton
KWR
A$2.21 B 5,146.61%๐Ÿ‡บ๐Ÿ‡ธ USA